New medical advancements are making surgery less invasive for those with Aortic Valve Disease. When the aortic heart valve ...
GlobalData on MSN
VDYNE secures FDA IDE to initiate pivotal trial for tricuspid regurgitation treatment
Linked to high mortality rates, current treatment options for tricuspid regurgitation remain extremely limited.
A valve-in-valve procedure for dysfunctional bioprosthetic mitral valves had lower 1-year risk for death and stroke than redo ...
The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...
In February, Mark Sorenson became the first patient at AdventHealth Daytona Beach to undergo a transcatheter tricuspid valve ...
Open heart surgery for aortic or mitral valve repair or replacement has traditionally required opening the patient’s chest through their sternum (breast bone). In many cases today, a minimally ...
Early valve replacement surgery for very severe asymptomatic aortic stenosis was tied to lower long-term mortality risk ...
The first RCT to compare valve-in-valve vs redo surgery reassures, especially for regions where rheumatic valve disease is prevalent.
Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement. While ...
For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...
John Cantrell was enjoying his retirement until an unexpected condition forced him to choose between two kinds of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results